In order to examine the protein levels of SH3KBP1 in vivo, we performed immunohistochemistry (IHC) staining using 27 clinical glioma patients’ specimens, including nine WHO grade II, 10 WHO grade III, eight WHO grade IV. Here, SH3KBP1 is linked to central nervous system cancer.